Institutional & Family Asset Management, LLC Ultragenyx Pharmaceutical Inc. Transaction History

Institutional & Family Asset Management, LLC

$846 Million
Q2 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 10, 2021	SELL	$92.19 - $115.71 $1,290 - $1,619	-14 Closed	0 $0
Q1 2021 May 06, 2021	SELL	$106.9 - $167.73 $855 - $1,341	-8 Reduced 36.36%	14 $2,000
Q4 2020 Feb 03, 2021	BUY	$84.4 - $177.39 $759 - $1,596	9 Added 69.23%	22 $3,000
Q2 2020 Aug 14, 2020	BUY	$46.91 - $78.22 $609 - $1,016	13 New	13 $1,000

Others Institutions Holding RARE

# of Institutions

329

Shares Held

85.9M

Call Options Held

520K

Put Options Held

406K

Vanguard Group Inc Valley Forge, PA

9.95M
Shares

$451 Million
0.01% of portfolio
Black Rock Inc. New York, NY

5.6M
Shares

$254 Million
0.01% of portfolio
Sands Capital Management, LLC Arlington, VA

5.12M
Shares

$232 Million
0.91% of portfolio
Wellington Management Group LLP Boston, MA

4.17M
Shares

$189 Million
0.04% of portfolio
Price T Rowe Associates Inc Baltimore, MD

3.07M
Shares

$139 Million
0.02% of portfolio

View Full List

About Ultragenyx Pharmaceutical Inc.

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.18B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

More about RARE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Institutional & Family Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Institutional & Family Asset Management, LLC with notifications on news.

Account